Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) EPS (Basic) (2020 - 2026)

Longeveron (LGVN) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 48.51% year-over-year from -$0.0 in Q1 2025, and up 27.77% quarter-over-quarter from -$0.0 in Q4 2025.

Longeveron (LGVN) EPS (Basic) (2020 - 2026) Analysis & Trends

Longeveron's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.0 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 48.51% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$0.0 (up 48.2% YoY), while the FY2025 annual figure was -$0.0, up 50.63% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.0, up from -$0.0 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.0 in Q1 2026, with the low at -$20.31 in Q1 2023.
  • The 5-year median for EPS (Basic) is -$1.83 (2024), against an average of -$2.41.
  • The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 17507.56% in 2022, then soared 99.99% in 2024.
  • Longeveron's EPS (Basic) stood at -$2.13 in 2022, then plunged by 30.48% to -$2.77 in 2023, then soared by 99.98% to -$0.0 in 2024, then increased by 28.57% to -$0.0 in 2025, then increased by 27.77% to -$0.0 in 2026.
  • Business Quant data shows LGVN's EPS (Basic) at -$0.0 in Q1 2026, -$0.0 in Q4 2025, and -$0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -0.20

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 -1.83
Mar 31, 2024 -1.72
Dec 31, 2023 -2.77
Sep 30, 2023 -2.79
Jun 30, 2023 -2.67
Mar 31, 2023 -20.31
Dec 31, 2022 -2.13
Sep 30, 2022 -2.50
Jun 30, 2022 -2.35
Mar 31, 2022 -1.96
Dec 31, 2021 23.74
Sep 30, 2021 -11.98